Persistent impaired glucose tolerance has similar rate of risk factors as for diabetes-Results of Indian Diabetes Prevention Programme (IDPP)

Diabetes Research and Clinical Practice

Volumn 73, Issue 1, 2006, Pages 100-103

  Ramachandran, A ^a   Snehalatha, C ^a   Mukesh, B ^a   Simon, Mary ^a   Kumar, C K Sathish ^a   Vijay, V ^a  

^a Diabetes Research Centre Tamil Nadu   (India)

Author keywords

Asian Indians; Impaired glucose tolerance; Lifestyle modification; Metformin; Prevention of diabetes

Indexed keywords

GLUCOSE; METFORMIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; BODY MASS; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INDIA; LIFESTYLE; MAJOR CLINICAL STUDY; RISK FACTOR; WAIST CIRCUMFERENCE;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INDIA; MALE; MIDDLE AGED; RISK FACTORS;

EID: 33747191230     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2005.12.002     Document Type: Article

References (11)

1. Alberti K.G.M.M. The clinical implications of impaired glucose tolerance. Diabet. Med. 13 (1996) 927-937
2. The Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl. J. Med. 346 (2002) 393-403
3. Tuomilehto J., Lindstrom J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New Engl. J. Med. 344 (2001) 1343-1350
4. Pan X., Li G., Hu Y., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance The Da Qing IGT and Diabetes study. Diab. Care 20 (1997) 537-544
5. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., and Laakso M. Acarbose for prevention of type 2 diabetes mellitus; the STOP-NIDDM randomized trial. Lancet 359 (2002) 2072-2077
6. Buchanan T.A., Xiang A.H., Peters R.K., et al. Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51 (2002) 2796-2803
7. The Diabetes Prevention Program Research Group. Prevention of type 2 diabetes with troglitazone in the diabetes prevention program. Diabetes 54 (2005) 1150-1156
8. Ramachandran A., Snehalatha C., Kapur A., et al., For the Diabetes Epidemiology Study Group in India (DESI). High Prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 44 (2001) 1094-1101
9. Ramachandran A., Snehalatha C., and Vijay V. Low risk threshold for acquired diabetogenic factors in Asian Indians. Diab. Res. Clin. Pract. 65 (2004) 189-195
10. A. Ramachandran, C. Snehalatha, S. Mary, B. Mukesh, A.D. Bhaskar, V. Vijay for the Indian Diabetes Prevention Programme (IDPP), Indian Diabetes Prevention Programme Shows that Lifestyle Modification and Metformin Prevent Type 2 Diabetes in Asian Indian Subjects with Impaired Glucose Tolerance (IDPP-1), Diabetologia, in press.
11. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Part 1: Diagnosis and Classification of Diabetes Mellitus (1999), Department of Non communicable Disease Surveillance, WHO, Geneva